Imaging techniques for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

Annals of Internal Medicine

Volumn 162, Issue 10, 2015, Pages 697-711

  Chou, Roger ^a   Cuevas, Carlos ^b   Fu, Rongwei ^c   Devine, Beth ^d   Wasson, Ngoc ^c   Ginsburg, Alexander ^e   Zakher, Bernadette ^c   Pappas, Miranda ^c   Graham, Elaine ^c   Sullivan, Sean D ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADOXETIC ACID; MANGAFODIPIR; PERFLUBUTANE; SUPERPARAMAGNETIC IRON OXIDE;

BILE DUCT CARCINOMA; BODY MASS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CLINICAL ASSESSMENT; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DATA SYNTHESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; LIVER; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER INJURY; LIVER SCINTISCANNING; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PEER REVIEW; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; REVIEW; SCOPUS; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC USE; LIVER NEOPLASMS;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84932113757     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2509     Document Type: Review

References (192)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-43. [PMID: 11905707]
2. National Cancer Institute. Liver and bile duct cancer. Accessed at www.cancer.gov/cancertopics/types/liver on 5 April 2015.
3. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2:S88-94. [PMID: 17877502]
4. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26: 6266-73. [PMID: 18848855] doi:10.1016/j.vaccine.2008.09.056
5. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-2. [PMID: 21374666] doi:10.1002/hep .24199
6. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol. 2009;193:55-60. [PMID: 19542395] doi:10.2214/AJR.09.2553
7. Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma [Editorial]. Radiology. 2013;266:376-82. [PMID: 23362092] doi:10.1148/radiol.12121698
8. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009;29:1725-48. [PMID: 19959518] doi:10.1148/rg.296095515
9. Frydrychowicz A, Lubner MG, Brown JJ, Merkle EM, Nagle SK, Rofsky NM, et al. Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging. 2012;35:492-511. [PMID: 22334493] doi:10.1002/jmri.22833
10. Altenbernd J, Heusner TA, Ringelstein A, Ladd SC, Forsting M, Antoch G. Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol. 2011;21:738-43. [PMID: 20936520] doi:10.1007/s00330-010-1964-7
11. Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W. Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics. 2011;31:1031-46; discussion 1047-50. [PMID: 21768237] doi:10.1148/rg.314105159
12. Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol. 2008;48: 848-57. [PMID: 18328590] doi:10.1016/j.jhep.2008.02.005
13. Chou R, Cuevas C, Fu R, Devine B, Wasson N, Ginsburg A, et al. Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma. Comparative Effectiveness Review No. 143. Prepared by the Pacific Northwest Evidence-based Practice Center under contract 290-2012-00014-I. Rockville, MD: Agency for Healthcare Research and Quality; October 2014. Accessed at http://effective healthcare.ahrq.gov/ehc/products/479/1990/liver-cancer-final-141022 .pdf on 30 March 2015.
14. Graham E, Ginsburg A, Wasson N, Chou R, Sullivan S, Cuevas C, et al. Imaging techniques for the surveillance, diagnosis, and staging of hepatocellular carcinoma. PROSPERO CRD42013005246. Accessed at www.crd.york.ac.uk/PROSPERO/display-record.asp?ID =CRD42013005246 on 11 November 2013.
15. Barr RG. Off-label use of ultrasound contrast agents for abdominal imaging in the United States. J Ultrasound Med. 2013;32:7-12. [PMID: 23269705]
16. Greenbaum L, Burns P, Copel J, Cosgrove D, Fowlkes JB, Goldberg B, et al; American Institute of Ultrasound in Medicine. American Institute of Ultrasound in Medicine recommendations for contrast-enhanced liver ultrasound imaging clinical trials. J Ultrasound Med. 2007;26:705-16. [PMID: 17526602]
17. Nelson TR, Fowlkes JB. Contrast-enhanced ultrasound: an idea whose time has come. J Ultrasound Med. 2007;26:703-4. [PMID: 17526601]
18. Chang SM, Matchar DB, eds. Methods Guide for Medical Test Reviews. AHRQ Publication no. 12-EHC017-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012. Accessed at http://effectivehealthcare.ahrq.gov/ehc/products/246/558/Methods-Guide-for-Medical-Test-Reviews-Full-Guide-20120530.pdf on 13 February 2015.
19. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-36. [PMID: 22007046] doi:10.7326/0003-4819-155-8-201110180-00009
20. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach [Letter]. J Clin Epidemiol. 2006;59:1331-2. [PMID: 17098577]
21. Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med. 2008;27:687-97. [PMID: 17611957]
22. Trikalinos TA, Balion CM, Coleman CI, Griffith L, Santaguida PL, Vandermeer B, et al. Chapter 8: meta-analysis of test performance when there is a "gold standard". J Gen Intern Med. 2012;27 Suppl 1:S56-66. [PMID: 22648676] doi:10.1007/s11606-012-2029-1
23. Takwoingi Y, Leeflang MM, Deeks JJ. Empirical evidence of the importance of comparative studies of diagnostic test accuracy. Ann Intern Med. 2013;158:544-54. [PMID: 23546566] doi:10.7326/0003-4819-158-7-201304020-00006
24. Singh S, Chang SM, Matchar DB, Bass EB. Chapter 7: grading a body of evidence on diagnostic tests. J Gen Intern Med. 2012;27 Suppl 1:S47-55. [PMID: 22648675] doi:10.1007/s11606-012-2021-9
25. Addley HC, Griffin N, Shaw AS, Mannelli L, Parker RA, Aitken S, et al. Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol. 2011;66:349-56. [PMID: 21295772] doi:10.1016/j .crad.2010.11.012
26. Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011;80:310-5. [PMID: 20732773] doi:10.1016/j .ejrad.2010.07.026
27. Alaboudy A, Inoue T, Hatanaka K, Chung H, Hyodo T, Kumano S, et al. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology. 2011;81 Suppl 1:66-72. [PMID: 22212939] doi:10.1159/000333264
28. Baccarani U, Adani GL, Avellini C, Lorenzin D, Curro G, Beltrami A, et al. Comparison of clinical and pathological staging and longterm results of liver transplantation for hepatocellular carcinoma in a single transplant center. Transplant Proc. 2006;38:1111-3. [PMID: 16757280]
29. Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, et al. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Clin Radiol. 2012;67:148-56. [PMID: 21920517] doi:10.1016/j.crad.2011.08.011
30. Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R. MnDPDPenhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol. 2000;10:1697-702. [PMID: 11097390]
31. Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig Surg. 2004;21:152-9. [PMID: 15166485]
32. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al; Barcelona Clinic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology. 2003;38:1034-42. [PMID: 14512891]
33. Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M, et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol. 2007;17:1066-73. [PMID: 17072617]
34. Chalasani N, Horlander JC Sr, Said A, Hoen H, Kopecky KK, Stockberger SM Jr, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol. 1999;94:2988-93. [PMID: 10520857]
35. Cheung TT, Ho CL, Lo CM, Chen S, Chan SC, Chok KS, et al. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation onthe basis of Milan criteria: surgeon's perspective. J Nucl Med. 2013; 54:192-200. [PMID: 23321459] doi:10.2967/jnumed.112.107516
36. Colagrande S, Fargnoli R, Dal Pozzo F, Bindi A, Rega L, Villari N. Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma. J Comput Assist Tomogr. 2000;24:878-83. [PMID: 11105704]
37. Dai Y, Chen MH, Fan ZH, Yan K, Yin SS, Zhang XP. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res. 2008;38:281-90. [PMID: 17908168]
38. de Le dinghen V, Laharie D, Lecesne R, Le Bail B, Winnock M, Bernard PH, et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol. 2002;14:159-65. [PMID: 11981340]
39. Denecke T, Grieser C, Froling V, Steffen IG, Rudolph B, Stelter L, et al. Multislice computed tomography using a triple-phase contrast protocol for preoperative assessment of hepatic tumor load in patients with hepatocellular carcinoma before liver transplantation. Transpl Int. 2009;22:395-402. [PMID: 19000231] doi:10.1111/j.1432-2277.2008.00793.x
40. Di Martino M, De Filippis G, De Santis A, Geiger D, Del Monte M, Lombardo CV, et al. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. Eur Radiol. 2013;23:887-96. [PMID: 23179521] doi:10.1007/s00330-012-2691-z
41. Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, et al. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 2010;256: 806-16. [PMID: 20720069] doi:10.1148/radiol.10091334
42. Doyle DJ, O'Malley ME, Jang HJ, Jhaveri K. Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr. 2007;31:86-92. [PMID: 17259838]
43. Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, et al. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)-a pilot study. Ultraschall Med. 2012;33:587-92. [PMID: 23154871] doi:10.1055/s-0032-1325545
44. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology. 2001;34:1109-12. [PMID: 11731999]
45. Freeman RB, Mithoefer A, Ruthazer R, Nguyen K, Schore A, Harper A, et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transpl. 2006;12:1504-11. [PMID: 16952174]
46. Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging. 2003;28:333-46. [PMID: 12719903]
47. Furuse J, Maru Y, Yoshino M, Mera K, Sumi H, Sekiguchi R, et al. Assessment of arterial tumor vascularity in small hepatocellular carcinoma. Comparison between color doppler ultrasonography and radiographic imagings with contrast medium: dynamic CT, angiography, and CT hepatic arteriography. Eur J Radiol. 2000;36:20-7. [PMID: 10996754]
48. Giorgio A, Ferraioli G, Tarantino L, de Stefano G, Scala V, Scarano F, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol. 2004;183:1319-26. [PMID: 15505297]
49. Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, et al. Small (=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-66. [PMID: 19697104] doi:10.1007/s11547-009-0439-x
50. Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, et al. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging. 2011;34:69-78. [PMID: 21598343] doi:10.1002/jmri.22588
51. Hidaka M, Takatsuki M, Okudaira S, Soyama A, Muraoka I, Tanaka T, et al. The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver. Hepatol Int. 2012:1-7.
52. Higashihara H, Osuga K, Onishi H, Nakamoto A, Tsuboyama T, Maeda N, et al. Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. Eur Radiol. 2012;22:872-9. [PMID: 22120061] doi:10.1007/s00330-011-2324-y
53. Hirakawa M, Yoshimitsu K, Irie H, Tajima T, Nishie A, Asayama Y, et al. Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. Jpn J Radiol. 2011;29:129-37. [PMID: 21359938] doi:10.1007/s11604-010-0528-8
54. Hori M, Murakami T, Kim T, Tsuda K, Takahashi S, Okada A, et al. Detection of hypervascular hepatocellular carcinoma: comparison of SPIO-enhanced MRI with dynamic helical CT. J Comput Assist Tomogr. 2002;26:701-10. [PMID: 12439302]
55. Hori M, Murakami T, Oi H, Kim T, Takahashi S, Matsushita M, et al. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium. Acta Radiol. 1998;39:144-51. [PMID: 9529444]
56. Hwang J, Kim SH, Lee MW, Lee JY. Small (=2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol. 2012;85:e314-22. [PMID: 22167508] doi: 10.1259/bjr/27727228
57. Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005;234:460-7. [PMID: 15671002]
58. Iavarone M, Sangiovanni A, Forzenigo LV, Massironi S, Fraquelli M, Aghemo A, et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology. 2010;52:1723-30. [PMID: 20842697] doi: 10.1002/hep.23903
59. Ichikawa T, Kitamura T, Nakajima H, Sou H, Tsukamoto T, Ikenaga S, et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol. 2002;179:751-8. [PMID: 12185057]
60. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrastenhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45:133-41. [PMID: 20098330] doi:10.1097/RLI.0b013e3181 caea5b
61. Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, et al. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol. 2012;47:1036-47. [PMID: 22526270] doi:10.1007/s00535-012-0571-6
62. Iwazawa J, Ohue S, Hashimoto N, Abe H, Hamuro M, Mitani T. Detection of hepatocellular carcinoma: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol. 2010;195:882-7. [PMID: 20858813] doi:10.2214/AJR.10.4417
63. Jang HJ, Kim TK, Khalili K, Yazdi L, Menezes R, Park SH, et al. Characterization of 1-to 2-cm liver nodules detected on HCC surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary? AJR Am J Roentgenol. 2013;201:314-21. [PMID: 23883211] doi: 10.2214/AJR.12.9341
64. Jang HJ, Lim JH, Lee SJ, Park CK, Park HS, Do YS. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology. 2000;215:373-80. [PMID: 10796910]
65. Jeng CM, Kung CH, Wang YC, Wu CY, Lee WY, Fan CK, et al. Spiral biphasic contrast-enhanced computerized tomography in the diagnosis of hepatocellular carcinoma. J Formos Med Assoc. 2002; 101:588-92. [PMID: 12440092]
66. Kakihara D, Nishie A, Harada N, Shirabe K, Tajima T, Asayama Y, et al. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography. J Magn Reson Imaging. 2014;40:1112-20. [PMID: 24259437] doi: 10.1002/jmri.24454
67. Kang BK, Lim JH, Kim SH, Choi D, Lim HK, Lee WJ, et al. Preoperative depiction of hepatocellular carcinoma: ferumoxidesenhanced MR imaging versus triple-phase helical CT. Radiology. 2003;226:79-85. [PMID: 12511672]
68. Kawada N, Ohkawa K, Tanaka S, Matsunaga T, Uehara H, Ioka T, et al. Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrastenhanced ultrasonography. Hepatol Res. 2010;40:930-6. [PMID: 20887598] doi:10.1111/j.1872-034X.2010.00697.x
69. Kawaoka T, Aikata H, Takaki S, Uka K, Azakami T, Saneto H, et al. FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma.Hepatol Res. 2009;39:134-42. [PMID: 19208034] doi:10.1111/j .1872-034X.2008.00416.x
70. Kawata S, Murakami T, Kim T, Hori M, Federle MP, Kumano S, et al. Multidetector CT: diagnostic impact of slice thickness on detection of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol. 2002;179:61-6. [PMID: 12076906]
71. Khalili K, Kim TK, Jang HJ, Haider MA, Khan L, Guindi M, et al. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization. J Hepatol. 2011;54:723-8. [PMID: 21156219] doi:10.1016/j .jhep.2010.07.025
72. Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol. 2000;32:792-7. [PMID: 10845666]
73. Kim KW, Lee JM, Klotz E, Park HS, Lee DH, Kim JY, et al. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology. 2009;250:425-434. [PMID: 19188314] doi:10.1148/radiol.2501072196
74. Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, et al. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;184:1069-76. [PMID: 15788575]
75. Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009; 192:1675-81. [PMID: 19457834] doi:10.2214/AJR.08.1262
76. Kim SJ, Kim SH, Lee J, Chang S, Kim YS, Kim SH, et al. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma. J Comput Assist Tomogr. 2008;32:379-85. [PMID: 18520541] doi:10.1097/RCT.0b013e3180de5c80
77. Kim SK, Lim JH, Lee WJ, Kim SH, Choi D, Lee SJ, et al. Detection of hepatocellular carcinoma: comparison of dynamic three-phase computed tomography images and four-phase computed tomography images using multidetector row helical computed tomography. J Comput Assist Tomogr. 2002;26:691-8. [PMID: 12439300]
78. Kim T, Murakami T, Hori M, Takamura M, Takahashi S, Okada A, et al. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking. AJR Am J Roentgenol. 2002;178:899-904. [PMID: 11906869]
79. Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Chon SB, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:149-57. [PMID: 16357395]
80. Kim YK, Kim CS, Han YM, Kwak HS, Jin GY, Hwang SB, et al. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr. 2009;33:844-50. [PMID: 19940648] doi:10.1097/RCT.0b013e3181a7e3c7
81. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology. 2006;238:531-41. [PMID: 16371577]
82. Kitamura T, Ichikawa T, Erturk SM, Nakajima H, Sou H, Araki T, et al. Detection of hypervascular hepatocellular carcinoma with multidetector-row CT: single arterial-phase imaging with computerassisted automatic bolus-tracking technique compared with double arterial-phase imaging. J Comput Assist Tomogr. 2008;32:724-9. [PMID: 18830101] doi:10.1097/RCT.0b013e318154b1f5
83. Kumano S, Uemura M, Haraikawa T, Hirata M, Kikuchi K, Kim T, et al. Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma. Jpn J Radiol. 2009;27:229-36. [PMID: 19626408] doi:10.1007/s11604-009-0327-2
84. Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, et al. Hepatocellular carcinoma: detection with triple-phase multidetector row helical CT in patients with chronic hepatitis. Radiology. 2003;226:543-9. [PMID: 12563152]
85. Lee CH, Kim KA, Lee J, Park YS, Choi JW, Park CM. Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI. Eur J Radiol. 2012;81:e605-11. [PMID: 22297180] doi:10.1016/j.ejrad.2011.12.033
86. Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, et al. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on Milan criteria: correlation with histopathological findings. Invest Radiol. 2009;44:311-21. [PMID: 19462486]
87. Lee J, Lee WJ, Lim HK, Lim JH, Choi N, Park MH, et al. Early hepatocellular carcinoma: three-phase helical CT features of 16 patients. Korean J Radiol. 2008;9:325-32. [PMID: 18682670] doi: 10.3348/kjr.2008.9.4.325
88. Lee JE, Jang JY, Jeong SW, Lee SH, Kim SG, Cha SW, et al. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan. World J Gastroenterol. 2012;18:2979-87. [PMID: 22736922] doi:10.3748/wjg.v18.i23.2979
89. Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Korean J Radiol. 2003;4:1-8. [PMID: 12679628]
90. Li CS, Chen RC, Tu HY, Shih LS, Zhang TA, Lii JM, et al. Imaging well-differentiated hepatocellular carcinoma with dynamic triplephase helical computed tomography. Br J Radiol. 2006;79:659-65. [PMID: 16641423]
91. Li R, Guo Y, Hua X, He Y, Ding J, Guo A, et al. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound. 2007;35:109-17. [PMID: 17295272]
92. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl. 2002;8:749-61. [PMID: 12200773]
93. Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol. 2002;179:67-73. [PMID: 12076907]
94. Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol. 2000;175:693-8. [PMID: 10954452]
95. Lin MT, Chen CL, Wang CC, Cheng YF, Eng HL, Wang JH, et al. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients. J Gastroenterol Hepatol. 2011;26:745-50. [PMID: 21418303] doi:10.1111/j.1440-1746.2010 .06501.x
96. Liu YI, Kamaya A, Jeffrey RB, Shin LK. Multidetector computed tomography triphasic evaluation of the liver before transplantation: importance of equilibrium phase washout and morphology for characterizing hypervascular lesions. J Comput Assist Tomogr. 2012;36: 213-9. [PMID: 22446362] doi:10.1097/RCT.0b013e318247c8f0
97. Liu YI, Shin LK, Jeffrey RB, Kamaya A. Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol. 2013; 200:84-9. [PMID: 23255745] doi:10.2214/AJR.11.7171
98. Lu CH, Chen CL, Cheng YF, Huang TL, Tsang LL, Ou HY, et al. Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases. Transplant Proc. 2010;42: 830-3. [PMID: 20430183] doi:10.1016/j.transproceed.2010.03.006
99. Luca A, Caruso S, Milazzo M, Mamone G, Marrone G, Miraglia R, et al. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol. 2010;20:898-907. [PMID: 19802612] doi:10.1007/s00330-009-1622-0
100. Luo W, Numata K, Morimoto M, Kondo M, Takebayashi S, Okada M, et al. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrastenhanced multidetector CT. Radiology. 2009;251:287-95. [PMID: 19221060] doi:10.1148/radiol.2511081324
101. Lv P, Lin XZ, Chen K, Gao J. Spectral CT in patients with small HCC: investigation of image quality and diagnostic accuracy. Eur Radiol. 2012;22:2117-24. [PMID: 22618521] doi:10.1007/s00330-012-2485-3
102. Maetani YS, Ueda M, Haga H, Isoda H, Takada Y, Arizono S, et al. Hepatocellular carcinoma in patients undergoing living-donor liver transplantation. Accuracy of multidetector computed tomography by viewing images on digital monitors. Intervirology. 2008;51 Suppl 1:46-51. [PMID: 18544948] doi:10.1159/000122597
103. Marin D, Catalano C, De Filippis G, Di Martino M, Guerrisi A, Rossi M, et al. Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. AJR Am J Roentgenol. 2009;192:180-7. [PMID: 19098199] doi:10.2214/AJR.07.3652
104. Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, et al. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumineenhanced MR imaging and multiphasic 64-section CT. Radiology. 2009;251:85-95. [PMID: 19332848] doi:10.1148/radiol.2511080400
105. Mita K, Kim SR, Kudo M, Imoto S, Nakajima T, Ando K, et al. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol. 2010;16:4187-92. [PMID: 20806437]
106. Monzawa S, Ichikawa T, Nakajima H, Kitanaka Y, Omata K, Araki T. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol. 2007; 188:147-53. [PMID: 17179357]
107. Moriyasu F, Itoh K. Efficacy of perflubutane microbubbleenhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86-95. [PMID: 19542399] doi:10.2214/AJR.08.1618
108. Mortele KJ, De Keukeleire K, Praet M, Van Vlierberghe H, de Hemptinne B, Ros PR. Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast-enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur Radiol. 2001;11:1631-8. [PMID: 11511882]
109. Murakami T, Kim T, Kawata S, Kanematsu M, Federle MP, Hori M, et al. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol. 2003;38:497-503. [PMID: 12874516]
110. Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology. 2001;218:763-7. [PMID: 11230652]
111. Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, et al. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int. 2006;26: 781-8. [PMID: 16911459]
112. Nakamura H, Ito N, Kotake F, Mizokami Y, Matsuoka T. Tumordetecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma. J Gastroenterol. 2000;35:849-55. [PMID: 11085494]
113. Nakamura Y, Tashiro H, Nambu J, Ohdan H, Kakizawa H, Date S, et al. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers. J Magn Reson Imaging. 2013;37:684-91. [PMID: 23055436] doi:10.1002/jmri.23855
114. Nakayama A, Imamura H, Matsuyama Y, Kitamura H, Miwa S, Kobayashi A, et al. Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg. 2001;234:56-62. [PMID: 11420483]
115. Noguchi Y, Murakami T, Kim T, Hori M, Osuga K, Kawata S, et al. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol. 2003;180:455-60. [PMID: 12540451]
116. Noguchi Y, Murakami T, Kim T, Hori M, Osuga K, Kawata S, et al. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase. J Comput Assist Tomogr. 2002;26:981-7. [PMID: 12488747]
117. Numata K, Fukuda H, Miwa H, Ishii T, Moriya S, Kondo M, et al. Contrast-enhanced ultrasonography findings using a perflubutanebased contrast agent in patients with early hepatocellular carcinoma. Eur J Radiol. 2014;83:95-102. [PMID: 24176532] doi:10.1016/j .ejrad.2013.09.025
118. Onishi H, Kim T, Imai Y, Hori M, Nagano H, Nakaya Y, et al. Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol. 2012;22:845-54. [PMID: 22057248] doi:10.1007/s00330-011-2316-y
119. Park JH, Kim SH, Park HS, Kim GH, Lee JY, Lee JM, et al. Added value of 80 kVp images to averaged 120 kVp images in the detection of hepatocellular carcinomas in liver transplantation candidates using dual-source dual-energy MDCT: results of JAFROC analysis. Eur J Radiol. 2011;80:e76-85. [PMID: 20875937] doi:10.1016/j.ejrad .2010.08.018
120. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology. 2000;217:743-9. [PMID: 11110938]
121. Pitton MB, Kloeckner R, Herber S, Otto G, Kreitner KF, Dueber C. MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2009;15:6044-51. [PMID: 20027676]
122. Pozzi Mucelli RM, Como G, Del Frate C, Iuri D, Furlan A, Al-Grhiw E, et al. Multidetector CT with double arterial phase and highiodine-concentration contrast agent in the detection of hepatocellular carcinoma. Radiol Med. 2006;111:181-91. [PMID: 16671376]
123. Pugacheva O, Matsui O, Kozaka K, Minami T, Ryu Y, Koda W, et al. Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography. Eur J Radiol. 2011;80:e201-6. [PMID: 20855175] doi: 10.1016/j.ejrad.2010.08.036
124. Quaia E, Alaimo V, Baratella E, Medeot A, Midiri M, Cova MA. The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiol. 2009;19:651-63. [PMID: 18815790] doi:10.1007/s00330-008-1179-3
125. Rizvi S, Camci C, Yong Y, Parker G, Shrago S, Stokes K, et al. Is post-Lipiodol CT better than i.v. contrast CT scan for early detection of HCC? A single liver transplant center experience. Transplant Proc. 2006;38:2993-5. [PMID: 17112883]
126. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr. 2001;25:327-36. [PMID: 11351179]
127. Ronzoni A, Artioli D, Scardina R, Battistig L, Minola E, Sironi S, et al. Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation. AJR Am J Roentgenol. 2007;189:792-8. [PMID: 17885047]
128. Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59:638-44. [PMID: 19951909] doi: 10.1136/gut.2009.187286
129. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology. 2011;261:834-44. [PMID: 21998047] doi:10.1148/radiol.11101840
130. Schima W, Hammerstingl R, Catalano C, Marti-Bonmati L, Rummeny EJ, Montero FT, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol. 2006;186:1571-9. [PMID: 16714645]
131. Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay AV, et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions-prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall Med. 2009;30:383-9. [PMID: 19688670] doi:10.1055/s-0028-1109673
132. Serste T, Barrau V, Ozenne V, Vullierme MP, Bedossa P, Farges O, et al. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology. 2012;55:800-6. [PMID: 22006503] doi:10.1002/hep.24746
133. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation. 2006; 81:1633-9. [PMID: 16794527]
134. Singh P, Erickson RA, Mukhopadhyay P, Gopal S, Kiss A, Khan A, et al. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc. 2007;66:265-73. [PMID: 17543307]
135. Sofue K, Tsurusaki M, Kawasaki R, Fujii M, Sugimura K. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multidetector row helical CT-a prospective randomized study. Eur J Radiol. 2011;80:e237-42. [PMID: 21067880] doi:10.1016/j.ejrad .2010.10.006
136. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003;226:533-42. [PMID: 12563151]
137. Toyota N, Nakamura Y, Hieda M, Akiyama N, Terada H, Matsuura N, et al. Diagnostic capability of gadoxetate disodiumenhanced liver MRI for diagnosis of hepatocellular carcinoma: comparison with multi-detector CT. Hiroshima J Med Sci. 2013;62:55-61. [PMID: 24279123]
138. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol. 1999;94:3314-9. [PMID: 10566736]
139. Valls C, Cos M, Figueras J, Andia E, Ramos E, Sanchez A, et al. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol. 2004;182:1011-7. [PMID: 15039179]
140. Van Thiel DH, Yong S, Li SD, Kennedy M, Brems J. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods. Liver Transpl. 2004;10:631-7. [PMID: 15108254]
141. Wagnetz U, Atri M, Massey C, Wei AC, Metser U. Intraoperative ultrasound of the liver in primary and secondary hepatic malignancies: comparison with preoperative 1.5-T MRI and 64-MDCT. AJR Am J Roentgenol. 2011;196:562-8. [PMID: 21343497] doi:10.2214/AJR.10.4729
142. Xiao XG, Han X, Shan WD, Li AY. Multi-slice CT angiography by triple-phase enhancement in preoperative evaluation of hepatocellular carcinoma. Chin Med J (Engl). 2005;118:844-9. [PMID: 15989766]
143. Yamamoto K, Shiraki K, Deguchi M, Sugimoto K, Sakai T, Ohmori S, et al. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography. Oncol Rep. 2002;9:789-92. [PMID: 12066210]
144. Yan FH, Shen JZ, Li RC, Zeng MS, Wu D, Zhou KR, et al. Enhancement patterns of small hepatocellular carcinoma shown by dynamic MRI and CT. Hepatobiliary Pancreat Dis Int. 2002;1:420-4. [PMID: 14607719]
145. Yoo SH, Choi JY, Jang JW, Bae SH, Yoon SK, Kim DG, et al. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol. 2013;20:2893-900. [PMID: 23649931] doi:10.1245/s10434-013-3001-y
146. Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:161-7. [PMID: 20920597] doi: 10.1016/j.cgh.2010.09.017
147. Yukisawa S, Okugawa H, Masuya Y, Okabe S, Fukuda H, Yoshikawa M, et al. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography. Eur J Radiol. 2007;61:279-89. [PMID: 17070663]
148. Zacherl J, Pokieser P, Wrba F, Scheuba C, Prokesch R, Zacherl M, et al. Accuracy of multiphasic helical computed tomography and intraoperative sonography in patients undergoing orthotopic liver transplantation for hepatoma: what is the truth? Ann Surg. 2002;235: 528-32. [PMID: 11923609]
149. Zhao H, Yao JL, Han MJ, Zhou KR, Yan FH. Multiphase hepatic scans with multirow-detector helical CT in detection of hypervascular hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2004;3: 204-8. [PMID: 15138110]
150. Zhao H, Yao JL, Wang Y, Zhou KR. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol. 2007;13:1252-6. [PMID: 17451209]
151. Zhao H, Zhou KR, Yan FH. Role of multiphase scans by multirow-detector helical CT in detecting small hepatocellular carcinoma. World J Gastroenterol. 2003;9:2198-201. [PMID: 14562377]
152. Zheng XH, Guan YS, Zhou XP, Huang J, Sun L, Li X, et al. Detectionof hypervascular hepatocellular carcinoma: Comparison ofmulti-detector CT with digital subtraction angiography and LipiodolCT. World J Gastroenterol. 2005;11:200-3. [PMID: 15633215]
153. Zhou KR, Yan FH, Tu BW. Arterial phase of biphase enhancementspiral CT in diagnosis of small hepatocellular carcinoma. HepatobiliaryPancreat Dis Int. 2002;1:68-71. [PMID: 14607626]
154. Hwang J, Kim YK, Kim JM, Lee WJ, Choi D, Hong SS. Pretransplantdiagnosis of hepatocellular carcinoma by gadoxetic acidenhancedand diffusion-weighted magnetic resonance imaging. Liver Transpl. 2014;20:1436-46. [PMID: 25103727] doi:10.1002/lt.239741
155. Mok TS, Yu SC, Lee C, Sung J, Leung N, Lai P, et al. Falsenegativerate of abdominal sonography for detecting hepatocellularcarcinoma in patients with hepatitis B and elevated serum alphafetoproteinlevels. AJR Am J Roentgenol. 2004;183:453-8. [PMID:15269040]
156. Paul SB, Gulati MS, Sreenivas V, Madan K, Gupta AK, MukhopadhyayS, et al. Evaluating patients with cirrhosis for hepatocellularcarcinoma: value of clinical symptomatology, imaging and alphafetoprotein. Oncology. 2007;72 Suppl 1:117-23. [PMID: 18087192]
157. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, DifloT, et al. Hepatocellular carcinoma and dysplastic nodules in patientswith cirrhosis: prospective diagnosis with MR imaging and explantationcorrelation. Radiology. 2001;219:445-54. [PMID: 11323471]
158. Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, DifloT, et al. Transplantation for hepatocellular carcinoma and cirrhosis:sensitivity of magnetic resonance imaging. Liver Transpl. 2002;8:1156-64. [PMID: 12474156]
159. Lauenstein TC, Salman K, Morreira R, Heffron T, Spivey JR, MartinezE, et al. Gadolinium-enhanced MRI for tumor surveillance beforeliver transplantation: center-based experience. AJR Am J Roentgenol. 2007;189:663-70. [PMID: 17715115]
160. Sec il M, Obuz F, Altay C, Gencel O, Igci E, Sagol O, et al. Therole of dynamic subtraction MRI in detection of hepatocellular carcinoma.Diagn Interv Radiol. 2008;14:200-4. [PMID: 19061165]
161. Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, et al. Smallhepatocellular carcinomas: improved sensitivity by combininggadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology. 2012;264:761-70. [PMID: 22843769] doi:10.1148/radiol.12112517
162. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, EmondJC, et al. An evaluation of the sensitivity of MRI at detecting hepatocellularcarcinoma in cirrhotic patients utilizing an explant referencestandard. Clin Imaging. 2014;38:693-7. [PMID: 24997104] doi:10.1016/j.clinimag.2014.05.014
163. Maiwald B, Lobsien D, Kahn T, Stumpp P. Is 3-tesla Gd-EOBDTPA-enhanced MRI with diffusion-weighted imaging superior to64-slice contrast-enhanced CT for the diagnosis of hepatocellularcarcinoma? PLoS One. 2014;9:e111935. [PMID: 25375778] doi:10.1371/journal.pone.0111935
164. Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, et al. Small (=1-cm) hepatocellular carcinoma: diagnostic performanceand imaging features at gadoxetic acid-enhanced MR imaging. Radiology. 2014;271:748-60. [PMID: 24588677] doi:10.1148/radiol.14131996
165. Goto E, Masuzaki R, Tateishi R, Kondo Y, Imamura J, Goto T,et al. Value of post-vascular phase (Kupffer imaging) by contrastenhancedultrasonography using Sonazoid in the detection of hepatocellularcarcinoma. J Gastroenterol. 2012;47:477-85. [PMID:22200940] doi:10.1007/s00535-011-0512-9
166. Kunishi Y, Numata K, Morimoto M, Okada M, Kaneko T, MaedaS, et al. Efficacy of fusion imaging combining sonography and hepatobiliaryphase MRI with Gd-EOB-DTPA to detect small hepatocellularcarcinoma. AJR Am J Roentgenol. 2012;198:106-14. [PMID:22194485] doi:10.2214/AJR.10.6039
167. Xu HX, Lu MD, Liu LN, Zhang YF, Guo LH, Xu JM, et al. Discriminationbetween neoplastic and non-neoplastic lesions in cirrhoticliver using contrast-enhanced ultrasound. Br J Radiol. 2012;85:1376-84. [PMID: 22553290] doi:10.1259/bjr/19932596
168. Xu HX, Xie XY, Lu MD, Liu GJ, Xu ZF, Zheng YL, et al. Contrastenhancedsonography in the diagnosis of small hepatocellular carcinoma=2 cm. J Clin Ultrasound. 2008;36:257-66. [PMID: 18088056]
169. Kim PN, Choi D, Rhim H, Rha SE, Hong HP, Lee J, et al. Planningultrasound for percutaneous radiofrequency ablation to treat small(=3 cm) hepatocellular carcinomas detected on computed tomographyor magnetic resonance imaging: a multicenter prospective studyto assess factors affecting ultrasound visibility. J Vasc Interv Radiol. 2012;23:627-34. [PMID: 22387030] doi:10.1016/j.jvir.2011.12.026
170. Lim JH, Kim SH, Lee WJ, Choi D, Kim SH, Lim HK. Ultrasonographicdetection of hepatocellular carcinoma: correlation of preoperativeultrasonography and resected liver pathology. Clin Radiol. 2006;61:191-7. [PMID: 16439225]
171. Liu WC, Lim JH, Park CK, Kim MJ, Kim SH, Lee SJ, et al. Poorsensitivity of sonography in detection of hepatocellular carcinoma inadvanced liver cirrhosis: accuracy of pretransplantation sonographyin 118 patients. Eur Radiol. 2003;13:1693-8. [PMID: 12835987]
172. Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, et al. Detection of hepatocellular carcinoma in gadoxetic acid-enhancedMRI and diffusion-weighted MRI with respect to the severity of livercirrhosis. Acta Radiol. 2012;53:830-8. [PMID: 22847903] doi:10.1258/ar.2012.120099
173. Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K,Abe Y, et al. Detection of hepatocellular carcinoma arising in cirrhoticlivers: comparison of gadolinium-and ferumoxides-enhancedMR imaging. AJR Am J Roentgenol. 1999;172:1547-54. [PMID:10350287]
174. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medicalliterature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?The Evidence-Based Medicine Working Group. JAMA. 1994;271:703-7. [PMID: 8309035]
175. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D,et al. Accuracy of ultrasonography, spiral CT, magnetic resonance,and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematicreview. Am J Gastroenterol. 2006;101:513-23. [PMID:16542288]
176. Westwood M, Joore M, Grutters J, Redekop K, Armstrong N,Lee K, et al. Contrast-enhanced ultrasound using SonoVue (sulphurhexafluoride microbubbles) compared with contrast-enhanced computedtomography and contrast-enhanced magnetic resonance imagingfor the characterisation of focal liver lesions and detection ofliver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2013;17:1-243. [PMID: 23611316] doi:10.3310/hta17160
177. Guang Y, Xie L, Ding H, Cai A, Huang Y. Diagnosis value of focalliver lesions with SonoVue-enhanced ultrasound compared withcontrast-enhanced computed tomography and contrast-enhancedMRI: a meta-analysis. J Cancer Res Clin Oncol. 2011;137:1595-605. [PMID: 21850382] doi:10.1007/s00432-011-1035-8
178. Xie L, Guang Y, Ding H, Cai A, Huang Y. Diagnostic value ofcontrast-enhanced ultrasound, computed tomography and magneticresonance imaging for focal liver lesions: a meta-analysis. UltrasoundMed Biol. 2011;37:854-61. [PMID: 21531500] doi:10.1016/j.ultrasmedbio.2011.03.006
179. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources ofheterogeneity in systematic reviews of diagnostic tests. Stat Med. 2002;21:1525-37. [PMID: 12111918]
180. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screeningtest accuracy evaluations: methodologic primer. AJR Am J Roentgenol. 2006;187:271-81. [PMID: 16861527]
181. Macaskill P, Gatsonis C, Deeks J, Harbord R, Takwoingi Y. Analysingand presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C,eds. Cochrane Handbook for Systematic Reviews of Diagnostic TestAccuracy. v 1.0. Oxford: The Cochrane Collaboration; 2010. Ac-cessed at http://srdta.cochrane.org/handbook-dta-reviews on 30March 2015.
182. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publicationbias and other sample size effects in systematic reviews ofdiagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882-93. [PMID: 16085191]
183. Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plotsand publication bias in meta-analyses of diagnostic accuracy. IntJ Epidemiol. 2002;31:88-95. [PMID: 11914301]
184. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial ofscreening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-22. [PMID: 15042359]
185. Hunt CH, Hartman RP, Hesley GK. Frequency and severity ofadverse effects of iodinated and gadolinium contrast materials: retrospectivereview of 456,930 doses. AJR Am J Roentgenol. 2009;193:1124-7. [PMID: 19770337] doi:10.2214/AJR.09.2520
186. Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology. 1995;196:439-43. [PMID: 7617858]
187. Niendorf HP, Haustein J, Cornelius I, Alhassan A, Clauss W. Safety of gadolinium-DTPA: extended clinical experience. MagnReson Med. 1991;22:222-8. [PMID: 1812350]
188. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P,Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of ContrastMedia. Radiology. 1990;175:621-8. [PMID: 2343107]
189. U.S. Food and Drug Administration. Micro-bubble contrastagents (marketed as Definity (perflutren lipid microsphere) injectablesuspension and Optison (perflutren protein-type A microspheresfor injection). 2013. Accessed at www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm092270.htm on 12 November 2013.
190. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicineand Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysisof 23188 investigations. Ultrasound Med Biol. 2006;32:1369-75. [PMID: 16965977]
191. Herzog CA. Incidence of adverse events associated withuse of perflutren contrast agents for echocardiography [Letter] JAMA. 2008;299:2023-5. [PMID: 18460662] doi:10.1001/jama.299.17.2023
192. Radiological Society of North America. Patient safety: radiationdose in x-ray and CT exams. Accessed at www.radiologyinfo.org/en/safety/index.cfm?pg=sfty-xray on 13 November 2013.